Deep Margin podcast

Episode 21: Alan Ho live (post hoc) from the Multidisciplinary Head and Neck Cancers Symposium

2026-05-31
0:00
39:56
Spola tillbaka 15 sekunder
Spola framåt 15 sekunder

Alan Ho, Medical oncologist at MSKCC talks us through his work around Ozuriftamab Vedotin (Oz-V) and other ADC approaches. Ben criticises Will's combination approaches.

Fler avsnitt från "Deep Margin"